#ICYMI We announced a license agreement for multiple clinical-stage compounds from AbbVie to expand and accelerate our pipeline of complementary modulators to combine with our novel NBD1 portfolio in #cysticfibrosis (CF). We believe we are well-positioned to advance our dual combination development path toward our goal of providing more efficacious #CF treatment options. Read our press release for details: https://lnkd.in/eTJgBmbr
Sionna Therapeutics
Biotechnology
Boston, MA 3,838 followers
Dedicated to delivering therapies that could be transformational for people living with cystic fibrosis.
About us
We are a life sciences company that is building on over a decade of extensive research on the genetic mutations associated with cystic fibrosis. We are developing first-in-class small molecules that are focused on a unique target with the potential to fully normalize CFTR function for the first time for the vast majority of people living with CF.
- Website
-
https://www.sionnatx.com/
External link for Sionna Therapeutics
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- Boston, MA
- Type
- Privately Held
- Founded
- 2019
- Specialties
- life sciences, biotechnology, pharmaceuticals, cystic fibrosis, protein function, genetics, genetic mutation, genetic disease, clinical research, clinical study, research, small molecule, molecular engineering, chemistry, patient advocacy, drug development, clinical development, lung, orphan disease, and rare disease
Locations
-
Primary
Boston, MA, US
Employees at Sionna Therapeutics
Updates
-
Since our start in 2019, we've remained committed to fostering strong connections among our team members and within the cystic fibrosis community. From recognizing our team’s achievements to supporting the Cystic Fibrosis Foundation's Great Strides Walk, and most recently, engaging in team-building activities on Cathleen Stone Island, we continually show that our dedication to collaboration goes beyond the workplace. Check out the ways we've strengthened our bonds and come together as a team in 2024!
-
Patrick Flume, M.D., Professor of Medicine and Pediatrics at the Medical University of South Carolina and one of our clinical advisors, is helping put our license agreement with AbbVie in context for people living with cystic fibrosis (CF). As we continue to expand our #CF pipeline, we benefit from Dr. Flume’s expert knowledge and guidance. For details: https://lnkd.in/eTJgBmbr
-
Check out this video from the Cystic Fibrosis Foundation featuring Gina Ruiz, a 29-year-old managing cystic fibrosis (CF). She talks about her journey with #CF and addresses common misconceptions associated with the condition. Watch the full video here: https://lnkd.in/efffHubA
CF Foundation | Dispelling Misconceptions About Cystic Fibrosis
https://www.youtube.com/
-
#ICYMI our Chief Medical Officer, Charlotte McKee, M.D., was featured on the "In Sickness" podcast, hosted by Robert Coughlin and Paul Kidwell, where they discussed cystic fibrosis (#CF) and the lifetime commitment needed for its care. Listen to the full episode here: https://lnkd.in/epumhBKZ
-
Our President & CEO, Michael Cloonan, shares his perspective on best practices for expanding a drug development pipeline strategically and efficiently in LifeSciVC’s recent "From The Trenches" blog organized by Bruce Booth of Atlas Venture. Read the full blog here: https://lnkd.in/ecMGrUKS
-
We are excited to announce that we have signed a license agreement for multiple clinical-stage modulators from AbbVie to accelerate our pipeline of complementary modulators to combine with NBD1 for #cysticfibrosis. For details, see our press release: https://lnkd.in/eTJgBmbr
-
We are expanding our portfolio of novel #smallmolecule therapies for cystic fibrosis, developed with the goal of restoring normal function to #CFTR, the key protein linked to disease in CF. Explore our differentiated approach to stabilizing NBD1: https://www.sionnatx.com/
-
#HiringAlert: We’re looking for an experienced professional to provide part-time support as a Quality Assurance Contractor (Director/Senior Director level). The individual will perform end-to-end Quality oversight and support GMP compliance of manufacturing strategies. Learn more: https://lnkd.in/dsaivp7X
-
The Cystic Fibrosis Foundation Compass resource offers personalized, one-on-one support to individuals and families navigating life with cystic fibrosis (CF), regardless of where they are in their #CF journey. Learn more: https://lnkd.in/ektaVTJC